Skip to main content
SpringerLink
Log in

Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

To analyse whether there exists a socio-economic gradient in utilisation of cardiovascular drugs at the district level in the Czech Republic.

Methods

The aggregated data on drug utilisation during the period 1997–2000, expressed in defined daily doses per 1000 inhabitants per day, were obtained from the General Health Insurance Company. Socio-economic characteristics of the districts in year 2000 (percentage of university-educated inhabitants, percentage of single-member households, number of ambulatory physicians per 10,000 inhabitants, unemployment rate and mean monthly income) were used as single unadjusted predictor variables. Partial correlation controlling for age in districts was used to analyse the relationship of cardiovascular disease (CVD) drug utilisation and several socio-economic variables.

Results

There were considerable differences in the utilisation of CVD drugs within the districts studied. Significantly higher utilisation of dihydropyridine Ca-channel blockers and statins was found in the districts with a higher percentage of university-educated inhabitants and more ambulatory physicians. CVD drug utilisation (nitrates, fibrates, selective β-blockers, verapamil and diltiazem and statins) correlated significantly with the percentage of single-member households. The five socio-economic variables explained more than 60% of the variability in use of dihydropyridine Ca-channel blockers, verapamil and diltiazem, ACE inhibitors and statins.

Conclusion

There exists a significant gradient in the utilisation of mainly newer CVD drug groups within districts of the Czech Republic that can be, at least partly, explained by social characteristics of the districts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Marmot M, Bobak M (2000) International comparators and poverty and health in Europe. Br Med J 321:1124–1128

    CAS  Google Scholar 

  2. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, White I, Brunner E, Feeney A (1991) Health inequalities among British civil servants: the Whitehall II study. Lancet 337:1387–1393

    Article  CAS  PubMed  Google Scholar 

  3. Glicksman MD, Lazarus R, Wilson A, Leeder SROV (1995) Social support, marital status and living arrangement correlates of cardiovascular disease risk factors in the elderly. Soc Sci Med 40:811–814

    Google Scholar 

  4. Kunst AE, Groehof F, Mackebach JP, The EU Working Group on Socio-economic Inequalities in Health (1998) Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. Br Med J 316:1636–1642

    CAS  Google Scholar 

  5. Mackebach JP, Kunst AE, Cavelaars AEJM, Groenhof F, Geurts JJM, The EU working group on socio-economic inequalities in health (1997) Socio-economic inequalities in morbidity and mortality in western Europe. Lancet 349:1655–1659

    Article  PubMed  Google Scholar 

  6. Bobak M, Hertzman C, Skodova Z, Marmot M (1999) Socio-economic status and cardiovascular risk factors in the Czech Republic. Int J Epidemiol 28:46–52

    Google Scholar 

  7. Dennis BH, Zhukovski GS, Shestov DB et al. (1993) The association of education with coronary heart disease in the USSR Lipid clinics research study. Int J Epidemiol 22:420–427

    CAS  PubMed  Google Scholar 

  8. Brajczewski C, Rogucka E (1993) Social class differences in rates of premature mortality among adults in the city of Wroclaw, Poland. Am J Hum Biol 5:461–471

    Article  Google Scholar 

  9. Eames M, Ben-Shlomo Y, Marmot MG (1993) Social deprivation and premature mortality: regional comparison across England. Br Med J 307:1097–1102

    CAS  Google Scholar 

  10. Dzúrová D (2000) Mortality differentials in the Czech Republic during the post-1989 socio-political transformation. Health Place 6:351–362

    Article  PubMed  Google Scholar 

  11. Pringle M, Morton-Jones A (1994) Using unemployment rates to predict prescribing trends in England. Br J Gen Pract 44:53–56

    Google Scholar 

  12. Bakken K, Eggen AE, Lund E (2001) Hormone replacement therapy in Norwegian women, 1996–1997. Maturitas 40:131–141

    Google Scholar 

  13. Nielsen MW, Hansen EH, Rasmussen NK (2004) Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey. Eur J Clin Pharmacol 60:199–204

    Article  PubMed  Google Scholar 

  14. Henricson K, Melander E, Mölstad S, Ranstam J, Hanson BS, Rametsteiner G, Stenberg P, Melander A (1998) Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors. Eur J Clin Pharmacol 57:653–657

    Article  Google Scholar 

  15. Majeed A, Ferguson J, Field J (1999) Prescribing of beta-2 agonists and inhaled steroids in England: trends between 1992 and 1998, and association with material deprivation, chronic illness and asthma mortality rates. J Publ Health Med 21:395–400

    Article  CAS  Google Scholar 

  16. Groenewegen PP, Leufkens HG, Spreeuwenberg P, Worm W (1999) Neighbourhood characteristics and use of benzodiazepines in The Netherlands. Soc Sci Med 48:1701–1711

    Article  CAS  PubMed  Google Scholar 

  17. Henricson K, Steberg P, Rametsteiner G (1998) Socio-economic factors, morbidity and drug utilisation—an ecological study. Pharmacoepidamiology Drug Safaty 7:261–267

    Article  CAS  Google Scholar 

  18. Packham C, Robinson J, Morris J, Richards C, Marks P, Gray D (1999) Statin prescribing in Nottingham general practices: a cross-sectional study. J Publ Health Med 21:60–64

    Article  CAS  Google Scholar 

  19. Merlo J, Lynch JW, Yang M, Lindström M, Östergren PO, Rasmusen NK, Råstam L (2003) Effect of neighbourhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol 157:774–783

    Article  PubMed  Google Scholar 

  20. WHO Collaborating Centre for Drug Statistics Methodology (2000) ATC Index With DDDs. Oslo, Norway

  21. Bruthans J, Dzůrová D (1999) Úmrtnost na nemoci oběhové soustavy v České republice po roce 1989. Demografie 41:193–206

    Google Scholar 

  22. Benzeval M, Judge K (1996) Access to health care in England: continuing inequalities in the distribution of GPs. J Publ Health Med 18:33–40

    CAS  Google Scholar 

  23. Agell M (2000) Is academic medicine for sale? N Engl J Med 342:1516–1518

    Google Scholar 

  24. Lloyd DCEF, Scrivener G (2001) Prescribing at the primary care group level: census data and prescribing indicators. J Clin Pharm Ther 26:93–101

    Article  CAS  PubMed  Google Scholar 

  25. Rathore SS, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh BJ, Schulman KA (2000) Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 102:642–648

    CAS  PubMed  Google Scholar 

  26. Duncan C, Jones K, Moon G (1998) Context, composition and heterogeneity: using multilevel models in health research. Soc Sci Med 46:97–117

    Article  CAS  PubMed  Google Scholar 

  27. Merlo J, Östergren PO, Hagberg O, Lindström M, Lindgren A, Melander A, Råstam L, Berglund G (2001) Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity. J Epidemiol Community Health 55:791–798

    Article  CAS  PubMed  Google Scholar 

  28. Diez Roux AV (2004) The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 26:104–111

    Article  PubMed  Google Scholar 

  29. Morgenstern H (1998) Ecological studies. In: Rothman KJ, Greenland S (ed) Modern epidemiology. Lippincott-Raven, Philadelphia, pp 459–480

    Google Scholar 

Download references

Acknowledgements

This project was supported by the Ministry of Education Grant CEZ: 13-98: 11600004. Authors wish to thank the General Health Insurance Company for providing data on drug utilisation.

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

  1. Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 02 Hradec Kralove, Czech Republic

    Kvetoslava Gorecka & Jiri Vlcek

  2. Hospital Pharmacy, Thomayers Teaching Hospital, Videnska 800, 140 00 Prague, Czech Republic

    Alena Linhartova

  3. Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 02 Hradec Kralove, Czech Republic

    Ivan Tilser

Authors
  1. Kvetoslava Gorecka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alena Linhartova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiri Vlcek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ivan Tilser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kvetoslava Gorecka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorecka, K., Linhartova, A., Vlcek, J. et al. Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic. Eur J Clin Pharmacol 61, 417–423 (2005). https://doi.org/10.1007/s00228-005-0929-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0929-2

Keywords

Search

Navigation